The most frequently described thrombophilia-related risk factor for CRAO is the occurrence of aPL, including LAC, aCL, and/or aβ2GPI antibodies, which was observed in more than one third of adult CRAO patients in a study by Dziedzic et al. [13]. This evidence concerns the gene LCT and Rare hereditary thrombophilia.